Susan H. Alexander

2019

In 2019, Susan H. Alexander earned a total compensation of $5.5M as Executive Vice President, Chief Legal Officer and Secretary at Biogen, a 14% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$164,782
Non-Equity Incentive Plan$1,033,451
Salary$772,373
Stock Awards$3,302,619
Other$181,785
Total$5,455,010

Alexander received $3.3M in stock awards, accounting for 61% of the total pay in 2019.

Alexander also received $164.8K of change in pension value and nonqualified deferred compensation earnings, $1M in non-equity incentive plan, $772.4K in salary and $181.8K in other compensation.

Rankings

In 2019, Susan H. Alexander's compensation ranked 1,959th out of 13,971 executives tracked by ExecPay. In other words, Alexander earned more than 86.0% of executives.

ClassificationRankingPercentile
All
1,959
out of 13,971
86th
Division
Manufacturing
713
out of 5,695
88th
Major group
Chemicals And Allied Products
216
out of 2,194
90th
Industry group
Drugs
173
out of 1,880
91st
Industry
Biological Products, Except Diagnostic Substances
41
out of 389
90th

Pay ratio

Susan H. Alexander's Pay$5,455,010
Median Employee's Pay$159,721
Pay Ratio

34

to 1

In 2019, the annual total compensation of Susan H. Alexander was $5,455,010.

The annual total compensation of the median employee at Biogen was $159,721.

The ratio of Susan H. Alexander's pay to the pay of median employee was therefore 34 to one.

Source: SEC filing on April 20, 2020.

Alexander's colleagues

We found five more compensation records of executives who worked with Susan H. Alexander at Biogen in 2019.

2019

Michel Vounatsos

Biogen

Chief Executive Officer

2019

Jeffrey Capello

Biogen

Chief Financial Officer

2019

Alfred Sandrock

Biogen

Executive Vice President, Research & Development

2019

Michael Ehlers

Biogen

Former Executive Vice President Research Development

2019

Chirfi Guindo

Biogen

Executive Vice President, Global Product Strategy and Commercialization

News

You may also like